Dr.reddy's Laboratories Ltd — Fluoxetine Exporter Profile
Indian Pharmaceutical Exporter · #8 for Fluoxetine · $4.7M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #8 Indian exporter of Fluoxetine with $4.7M in export value and 172 verified shipments. Dr.reddy's Laboratories Ltd holds a 2.5% market share in Fluoxetine exports across 7 countries.
Dr.reddy's Laboratories Ltd — Fluoxetine Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Fluoxetine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.5M | 184 | 96.1% |
| UNITED KINGDOM | $87.5K | 3 | 2.4% |
| AUSTRALIA | $31.1K | 4 | 0.9% |
| MALDIVES | $10.2K | 1 | 0.3% |
| GERMANY | $7.6K | 4 | 0.2% |
| MAURITIUS | $5.0K | 3 | 0.1% |
| BRAZIL | $74 | 2 | 0.0% |
Dr.reddy's Laboratories Ltd exports Fluoxetine to 7 countries. The largest destination is UNITED STATES accounting for 96.1% of Dr.reddy's Laboratories Ltd's Fluoxetine shipments, followed by UNITED KINGDOM (2.4%) and AUSTRALIA (0.9%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluoxetine from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR. REDDYS LABORATORIES, INC | UNITED STATES | $1.3M | 45 |
| DR REDDYS LABORATORIES,INC | UNITED STATES | $504.6K | 31 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $476.0K | 41 |
| DR .REDDYS LABORATORIES INC | UNITED STATES | $354.4K | 14 |
| DR. REDDY'S LABORATORIES, INC | UNITED STATES | $333.4K | 23 |
| DR. REDDYS LABORATORIES INC | UNITED STATES | $241.1K | 9 |
| DR. REDDYS LABORATORIES,INC | UNITED STATES | $83.2K | 6 |
| DR.REDDYS LABORATORIES INC | UNITED STATES | $52.0K | 3 |
| DR.REDDYS LABORATORIES INC. | UNITED STATES | $50.0K | 1 |
| MOVIANTO UK LTD, | UNITED KINGDOM | $39.0K | 1 |
Dr.reddy's Laboratories Ltd supplies Fluoxetine to 25 buyers globally. The largest buyer is DR. REDDYS LABORATORIES, INC (UNITED STATES), followed by DR REDDYS LABORATORIES,INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluoxetine Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $59.0M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. Dr.reddy's Laboratories Ltd contributes $4.7M to this total, accounting for 2.5% of India's Fluoxetine exports. Dr.reddy's Laboratories Ltd ships Fluoxetine to 7 countries through 25 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Fluoxetine Exports?
Dr.reddy's Laboratories Ltd's average Fluoxetine shipment value is $27.3K per consignment, based on 172 shipments totaling $4.7M. The largest destination is UNITED STATES (96.1% of Dr.reddy's Laboratories Ltd's Fluoxetine exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Fluoxetine Exporters?
Dr.reddy's Laboratories Ltd ranks #8 among 253 Indian Fluoxetine exporters with a 2.5% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), MICRO LABS LIMITED ($7.7M), ALEMBIC PHARMACEUTICALS LIMITED ($5.8M). Dr.reddy's Laboratories Ltd processed 172 shipments to 7 destination countries.
What Fluoxetine Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUOXETINE TABLETS USP 20MG 100S (TOTAL | $443.0K | 13 |
| FLUOXETINE TABLETS USP 10MG (57528 X 30S | $203.7K | 7 |
| FLUOXETINE TABLETS USP 10MG USA (17304 X | $150.8K | 7 |
| FLUOXETINE DELAYED-RELEASE CAPSULES USP90MG 4S (TOTAL QTY PACKS 8640X4S=34560NOS)NOS | $150.0K | 3 |
| 300009183 FLUOXETINE DELAYED-RELEASE CAPSULES USP 90MG 4S (18000 SU X 4=72,000 NOS)NOS | $150.0K | 3 |
| FLUOXETINE TABLETS USP 60MG 30S (TOTAL | $107.6K | 3 |
| FLUOXETINE TABLETS USP 20MG 100S (53160X 100S PACKS=5316000 NOS)NOS | $91.2K | 3 |
| FLUOXETINE TABLETS USP 10MG (27144 X 30S | $83.2K | 6 |
| FLUOXETINE TABLETS USP 20MG 100S (TOTALQTY PACKS 42864 X 100S=4286400 NOS) | $72.2K | 3 |
| FLUOXETINE TABLETS USP 10MG 100S USA (T | $64.9K | 2 |
Dr.reddy's Laboratories Ltd exports 100 distinct Fluoxetine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUOXETINE TABLETS USP 20MG 100S (TOTAL with 13 shipments worth $443.0K.
Regulatory Requirements: Exporting Fluoxetine to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Fluoxetine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Fluoxetine Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED | $5.0M | 99 | 1 | $50.0K |
| 2 | INTAS PHARMACEUTICALS LIMITED | $4.8M | 97 | 7 | $50.0K |
| 8 | DR.REDDY'S LABORATORIES LTD ★ | $4.7M | 172 | 7 | $27.3K |
| 9 | APL HEALTHCARE LIMITED | $3.6M | 73 | 1 | $48.9K |
| 10 | CIPLA LIMITED | $3.0M | 92 | 4 | $32.5K |
Dr.reddy's Laboratories Ltd ranks #8 among 253 Indian Fluoxetine exporters. Average shipment value of $27.3K compared to the market average of $233.1K. The closest competitors by value are SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Fluoxetine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 603 | 16.3% |
| SAHAR AIR | 508 | 13.7% |
| NHAVA SHEVA SEA (INNSA1) | 285 | 7.7% |
| MUNDRA SEA | 150 | 4.1% |
| MUNDRA SEA (INMUN1) | 129 | 3.5% |
| Bombay Air | 119 | 3.2% |
| DELHI AIR | 110 | 3.0% |
| HYDERABAD ICD (INSNF6) | 108 | 2.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 201 individual customs records matching Dr.reddy's Laboratories Ltd exporting Fluoxetine, covering 100 formulations to 7 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Fluoxetine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Fluoxetine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current shipment-level data, contact TransData Nexus.